Lucknow Endocrine Diabetes And Thyroid Clinic Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.10 M
as on 23-12-2024
- Revenue 76.48%
(FY 2020)
- Profit 62.67%
(FY 2020)
- Ebitda 95.78%
(FY 2020)
- Net Worth 83.70%
(FY 2020)
- Total Assets 83.62%
(FY 2020)
About Lucknow Endocrine Diabetes And Thyroid Clinic
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.10 M.
Arunkumar Pande and Samiksha Pandey serve as directors at the Company.
- CIN/LLPIN
U85300UP2017PTC092843
- Company No.
092843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lucknow Endocrine Diabetes And Thyroid Clinic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunkumar Pande  | Director | 02-May-2017 | Current |
| Samiksha Pandey | Director | 02-May-2017 | Current |
Financial Performance of Lucknow Endocrine Diabetes And Thyroid Clinic.
Lucknow Endocrine Diabetes And Thyroid Clinic Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 76.48% increase. The company also saw a substantial improvement in profitability, with a 62.67% increase in profit. The company's net worth Soared by an impressive increase of 83.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lucknow Endocrine Diabetes And Thyroid Clinic?
Unlock access to Lucknow Endocrine Diabetes And Thyroid Clinic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Saaswa Medical Analysis Private LimitedActive 2 years 3 monthsArunkumar Pande and Samiksha Pandey are mutual person
Charges (Loans)
₹3.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2023 | Others | ₹3.10 M | Open |
How Many Employees Work at Lucknow Endocrine Diabetes And Thyroid Clinic?
Unlock and access historical data on people associated with Lucknow Endocrine Diabetes And Thyroid Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucknow Endocrine Diabetes And Thyroid Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucknow Endocrine Diabetes And Thyroid Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.